By Viviane Trojan
April 10, 2025
Life Sciences Brazil Global Guide 2025 | Chambers & Partners
We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2025 Global Practice Guide!
Our partners Priscila Kashiwabara and Viviane Trojan, along with attorneys Gustavo Vicenti and Giovanna Verginelli Mezher, authored the Life Sciences 2025 guide for Brazil. This guide outlines the regulatory framework for pharmaceuticals and medical devices, detailing legislation, regulatory bodies, and procedures for approvals and appeals. It covers categorization, clinical trials, marketing authorizations, and ongoing obligations.
The guide also emphasizes ANVISA’s role in regulation, stringent requirements for biologics, and procedures for compassionate use and post-marketing surveillance. Additionally, it addresses manufacturing authorizations, distribution regulations, and measures against counterfeit products.
Click here to read the full article: https://lnkd.in/dbU5yrvD.
Share:
Last by Viviane Trojan
April 16, 2025
Medicinal Cannabis Review: Public Consultation 1.316/2025 open
The Public Consultation (CP) No. 1.316/2025, which aims to initiate the review process of Collegiate Board Resolution (RDC) No. 327/2019 from the … Medicinal Cannabis Review: Public Consultation 1.316/2025 open
April 15, 2025
Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required
The Federal Senate has approved a bill (PLS nº 404/2018) that extends the protection period for new plant varieties (cultivars). According to … Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required
April 10, 2025
Life Sciences Brazil Global Guide 2025 | Chambers & Partners
We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2025 Global Practice Guide! Our partners Priscila Kashiwabara … Life Sciences Brazil Global Guide 2025 | Chambers & Partners